January 31, 2025 • 9:15 am EST TerrAscend Announces Preliminary Fourth Quarter 2024 Financial Results and Schedules Earnings Conference Call
November 26, 2024 • 5:28 pm EST TerrAscend Appoints Lynn Gefen to Expanded Role of Chief People Officer
November 6, 2024 • 4:02 pm EST TerrAscend Enters Ohio with the Signing of Definitive Agreement to Acquire a Well Situated and Profitable Dispensary
October 1, 2024 • 8:30 am EDT TerrAscend Closes on Remaining US$26 Million Draw of US$140 Million Debt Financing
September 5, 2024 • 8:30 am EDT TerrAscend to Participate in the ATB Capital Markets 2024 Life Sciences Institutional Investor Conference on September 18th in NYC